ArticleANZ journal of surgery
A Novel Blood-Based Screening Test for Colorectal Cancer Using Raman Spectroscopy.
Article in ANZ journal of surgery. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLabel-free vibrational spectroscopic techniques (Raman spectroscopy) combined with machine learning (ML) methodologies have huge potential for the development of screening and diagnostic tests in oncology. Traditionally, screening for colorectal cancer (CRC) has relied on immunochemical faecal occult blood (iFOBT) testing; however, this has shown to have low compliance in the Australian setting. The aim of this study was to assess the efficacy of Raman spectroscopy for the detection of CRC and potential screening for CRC.
methodsPlasma samples were analysed from a total of 370 participants; 117 CRC patients and 253 iFOBT positive control participants. 8 of the CRC patients were from the iFOBT cohort. The control cohort had either advanced adenomas (n = 81), non-advanced adenomas (n = 76), colitis (n = 2) or no evidence of disease (n = 94). The Raman spectra of these plasma samples were analysed using ML algorithms in separate training (n = 222) and validation (n = 148) cohorts.
resultsA sensitivity of 84% and specificity of 93% was achieved for the detection of CRC in the validation cohort. When analysed in subcategories, 95% of people with CRC would receive a colonoscopy and 42% of FIT positive people could potentially be spared a colonoscopy.
conclusionThis exploratory study demonstrated a high level of accuracy for the detection of CRC using a Raman spectroscopy-based ML model and has the potential to be used for CRC screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.